UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $44,000 | -94.5% | 1,198 | -93.5% | 0.00% | -95.4% |
Q4 2018 | $798,000 | -6.8% | 18,519 | +2.1% | 0.06% | +20.4% |
Q3 2018 | $856,000 | -10.6% | 18,133 | -5.7% | 0.05% | -12.9% |
Q2 2018 | $957,000 | +1814.0% | 19,223 | +1797.6% | 0.06% | +1966.7% |
Q1 2018 | $50,000 | – | 1,013 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |